In my opinion, virco®TYPE HIV-1 is a viable alternative to a conventional phenotype that provides me with similar information to a conventional phenotype.
What's New
These modules are presented in an easy to navigate format and begin with a history of the HIV/AIDS epidemic and current epidemiology.
November 2009
Volume 1, Number 3
Presented by Dr. Rafael E. Campo
A 49-year-old African American male, with a history of IDU, unexpectedly presents to the clinic with viremia and declining CD4 cell count after being lost to follow-up for 2.5 years..
Updated December 1, 2009 — Antiretroviral Guidelines for Adults and Adolescents: Drug Resistance Testing
Resistance Poll
HIV Resistance Resources
Virco QuickSpots
Presented by Harold A. Kessler, MD
Professor of medicine and Immunology/Microbiology at Rush University Medical Center in Chicago Illinois (USA) .
QuickSpot 1: View this brief presentation and learn how viral mixtures can contribute to treatment failure... More >
QuickSpot 2: View this brief presentation and learn about combination based approach to viral mixtures... More >
HIV Learning Modules
These modules are presented in an easy to navigate format and begin with a history of the HIV/AIDS epidemic and current epidemiology.
Also included are details of the pathophysiology and the science behind the disease, an overview of the drugs used to treat HIV/AIDS and an extensive section on drug resistance and the use of resistance assays to guide the selection of antiretroviral therapy. More >
Clinical Cases in HIV Resistance
Clinical Cases in HIV Resistance is an ongoing series of patient profiles that illustrate key practice points for clinicians on the use and interpretation of resistance tests in the overall care of HIV-infected patients. More >
July 2009
Volume 1, Number 3
Presented by Dr. Rafael E. Campo
A 49-year-old African American male, with a history of IDU, unexpectedly presents to the clinic with viremia and declining CD4 cell count after being lost to follow-up for 2.5 years.. More >
Virco Product Monograph
These sets of slides were developed to describe the virco®TYPE HIV-1 Report and to assist HIV clinicians in better understanding the analytical processes used to transform an abundance of data into relevant clinical information. More >
Quick Links
virco® TYPE HIV-1
This module is presented in an easy to navigate format with audio that explains how to read and use all the information in the virco®TYPE HIV-1. More >